TriSalus Life Sciences Statistics
Total Valuation
TLSI has a market cap or net worth of $175.79 million. The enterprise value is $190.89 million.
Important Dates
The last earnings date was Thursday, March 27, 2025, before market open.
| Earnings Date | Mar 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TLSI has 31.28 million shares outstanding. The number of shares has increased by 169.61% in one year.
| Current Share Class | 31.28M |
| Shares Outstanding | 31.28M |
| Shares Change (YoY) | +169.61% |
| Shares Change (QoQ) | +3.96% |
| Owned by Insiders (%) | 27.70% |
| Owned by Institutions (%) | 38.84% |
| Float | 19.86M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.84 |
| Forward PS | 3.84 |
| PB Ratio | -6.79 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.49 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.02
| Current Ratio | 2.02 |
| Quick Ratio | 1.33 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.70 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -90.97% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -263.15% |
| Revenue Per Employee | $262,777 |
| Profits Per Employee | -$296,723 |
| Employee Count | 112 |
| Asset Turnover | 1.18 |
| Inventory Turnover | 1.24 |
Taxes
In the past 12 months, TLSI has paid $6,000 in taxes.
| Income Tax | 6,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -40.47% in the last 52 weeks. The beta is 0.48, so TLSI's price volatility has been lower than the market average.
| Beta (5Y) | 0.48 |
| 52-Week Price Change | -40.47% |
| 50-Day Moving Average | 5.39 |
| 200-Day Moving Average | 4.99 |
| Relative Strength Index (RSI) | 55.78 |
| Average Volume (20 Days) | 67,575 |
Short Selling Information
The latest short interest is 124,046, so 0.40% of the outstanding shares have been sold short.
| Short Interest | 124,046 |
| Short Previous Month | 136,143 |
| Short % of Shares Out | 0.40% |
| Short % of Float | 0.62% |
| Short Ratio (days to cover) | 3.13 |
Income Statement
In the last 12 months, TLSI had revenue of $29.43 million and -$33.23 million in losses. Loss per share was -$1.31.
| Revenue | 29.43M |
| Gross Profit | 25.33M |
| Operating Income | -36.17M |
| Pretax Income | -63.97M |
| Net Income | -33.23M |
| EBITDA | -35.43M |
| EBIT | -36.17M |
| Loss Per Share | -$1.31 |
Full Income StatementBalance Sheet
The company has $8.53 million in cash and $23.63 million in debt, giving a net cash position of -$15.10 million or -$0.48 per share.
| Cash & Cash Equivalents | 8.53M |
| Total Debt | 23.63M |
| Net Cash | -15.10M |
| Net Cash Per Share | -$0.48 |
| Equity (Book Value) | -25.89M |
| Book Value Per Share | -0.83 |
| Working Capital | 10.44M |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 86.06%, with operating and profit margins of -122.88% and -102.09%.
| Gross Margin | 86.06% |
| Operating Margin | -122.88% |
| Pretax Margin | -102.07% |
| Profit Margin | -102.09% |
| EBITDA Margin | -120.38% |
| EBIT Margin | -122.88% |
| FCF Margin | n/a |